Showing results (431-440 of 2,510) with videos related to
Sort By:
Pageof 251
Journal of the International AIDS Society|November 15, 2014
Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohortClotilde Allavena, Christine Katlama, Laurent Cotte, et al.Journal of the International AIDS Society|November 15, 2014
Impact of etravirine use on hospitalization rates among highly pre-treated failing HIV-1 infected individuals between 2005 and 2011Jean-Marc Lacombe, Cecile Goujard, Marc-Antoine Valantin, et al.Journal of the International AIDS Society|November 15, 2014
Effectiveness and durability of darunavir/ritonavir (DRV/r) in DRV/r-experienced HIV-1-infected patients in routine clinical practiceAndrea Antinori, Massimo Galli, Nicola Gianotti, et al.Journal of the International AIDS Society|November 15, 2014
Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNAClaudia Bianco, Genny Meini, Barbara Rossetti, et al.Journal of the International AIDS Society|November 15, 2014
Renal safety profile of STB in virologically suppressed subjects from two randomized phase 3b switch trialsIain Reeves, Martin Fisher, Stephen Kegg, et al.Journal of the International AIDS Society|November 15, 2014
Unboosted atazanavir with lamivudine/emtricitabine for patients with long-lasting virological suppressionAlessia Carbone, Laura Galli, Alba Bigoloni, et al.Journal of the International AIDS Society|November 15, 2014
Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohortCarmela Pinnetti, Simona Di Giambenedetto, Franco Maggiolo, et al.Journal of the International AIDS Society|November 15, 2014
ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR studyDaniel Podzamczer, Nerea Rozas, Pere Domingo, et al.Journal of the International AIDS Society|November 15, 2014
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centreAlberto Borghetti, Annalisa Mondi, Benedetta Piccoli, et al.Journal of the International AIDS Society|November 15, 2014
Nuke-sparing regimens as a main simplification strategy and high level of toxicity resolution after antiretroviral switch: the SWITCHART StudyAna Carrero-Gras, Antonio Antela, Jessica Muñoz-Rodríguez, et al.Pageof 251